Drug Combination Details
| General Information of the Combination (ID: C37217) | |||||
|---|---|---|---|---|---|
| Name | Vancomycin NP Info | + | Cisplatin Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Healthy individual
[ICD-11: N.A.]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Decreasing Adverse Drug Reaction by This Combination | ||||||
| Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| Biological
Regulation |
Reduction | Cisplatin-induced lipid peroxidation | ||||
| In-vivo Model | Healthy adult male albino rats (8-10 weeks old; weighing 120-180 g) of Wistar strain were used in this study. | |||||
| Experimental
Result(s) |
Vanillic acid is a potential antioxidant that reduce cisplatin nephrotoxicity and can be as a combinatorial regimen in cancer chemotherapy. | |||||